LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

LLY

1,076.96

+0.06%↑

JNJ

207.49

-0.14%↓

ABBV

230.16

+0.01%↑

UNH

331.59

+1.17%↑

AZN

92.89

+0.42%↑

Inicio・Lista de Acciones・Lisata Therapeutics

L
Lisata Therapeutics

Cerrado

1.88 -6.47

Comprar Vender

Resumen

Variación precio

24h

Actual

Mínimo

1.88

Máximo

1.9300000000000002

Métricas clave
By Trading Economics
Empleados	26

Estadísticas de Mercado
By TradingEconomics
Capitalización de Mercado	-4.7M 15M
Apertura anterior	8.35
Cierre anterior	1.88

Lisata Therapeutics Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

24 dic 2025, 21:41 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20 Billion, CNBC Reports

26 dic 2025, 20:22 UTC

Charlas de Mercado

Oil Loses Ground On Russia-Ukraine Peace Efforts -- Market Talk

26 dic 2025, 20:13 UTC

Charlas de Mercado

U.S. Natural Gas Gains on Colder Weather Outlook -- Market Talk

26 dic 2025, 19:24 UTC

Adquisiciones, fusiones, absorciones

Nvidia's Groq Deal Is an Instagram Moment -- With 1 Big Risk -- Barrons.com

26 dic 2025, 17:45 UTC

Charlas de Mercado

U.S. Diesel Down on Lower Crude Prices, Freight-Sector Lull -- Market Talk

26 dic 2025, 15:52 UTC

Charlas de Mercado

Oil Futures Turn Lower After Steady Start -- Market Talk

26 dic 2025, 14:58 UTC

Charlas de Mercado

Silver, Gold Reach New Highs Amid Geopolitical Tension -- Market Talk

26 dic 2025, 14:41 UTC

Charlas de Mercado

U.S. Natural Gas Futures Look to End Week Higher -- Market Talk

26 dic 2025, 14:28 UTC

Charlas de Mercado

Dollar Indexes Flat as Yen Rally Wanes -- Market Talk

26 dic 2025, 13:47 UTC

Charlas de Mercado

Oil Futures Steady in Thin Holiday Trade -- Market Talk

26 dic 2025, 07:22 UTC

Charlas de Mercado

Comex Gold Futures' Strong Bullish Momentum in Play, Chart Shows -- Market Talk

26 dic 2025, 05:03 UTC

Charlas de Mercado

Malaysian Ringgit Likely to Face Pressure From Dollar Strength in 1Q -- Market Talk

26 dic 2025, 03:38 UTC

Charlas de Mercado

Global Equities Roundup: Market Talk

26 dic 2025, 03:38 UTC

Charlas de Mercado

Korean Won Strengthens, Supported by Verbal Interventions -- Market Talk

26 dic 2025, 02:44 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

26 dic 2025, 02:44 UTC

Charlas de Mercado

Singapore Dollar Weakens Slightly on Likely Position Adjustments -- Market Talk

26 dic 2025, 01:39 UTC

Charlas de Mercado

China's Central Bank Signals Possibility of Easing Policy in Coming Months -- Market Talk

26 dic 2025, 01:14 UTC

Charlas de Mercado

Oil Edges Higher Amid Geopolitical Tensions -- Market Talk

26 dic 2025, 00:34 UTC

Charlas de Mercado

Yen Mostly Weakens Amid Risk-on Sentiment -- Market Talk

26 dic 2025, 00:15 UTC

Charlas de Mercado

Nikkei Gains 0.6%, Led by Tech, Videogame Stocks -- Market Talk

25 dic 2025, 23:42 UTC

Charlas de Mercado

Nikkei May Trade in Range; Yen in Focus -- Market Talk

25 dic 2025, 23:40 UTC

Charlas de Mercado

Gold Edges Higher Amid Geopolitical Risks -- Market Talk

25 dic 2025, 00:20 UTC

Adquisiciones, fusiones, absorciones

Nike Climb Boosts Dow, S&P 500 -- 2nd Update

24 dic 2025, 22:22 UTC

Adquisiciones, fusiones, absorciones

Nvidia, Groq Strike AI Tech Licensing Deal -- Barrons.com

24 dic 2025, 21:26 UTC

Adquisiciones, fusiones, absorciones

Nvidia to Buy Chip-Designer Groq for $20B, CNBC Reports

24 dic 2025, 19:35 UTC

Charlas de Mercado

Global Forex and Fixed Income Roundup: Market Talk

24 dic 2025, 19:35 UTC

Charlas de Mercado

Treasury Yields Decline Ahead of Christmas -- Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

Global Equities Roundup: Market Talk

24 dic 2025, 19:09 UTC

Charlas de Mercado

Adquisiciones, fusiones, absorciones

ServiceNow's Armis Acquisition Shouldn't Fuel Fears That Seat-Based Model Threatened -- Market Talk

24 dic 2025, 19:06 UTC

Charlas de Mercado

Oil Futures Little Changed in Light Pre-Holiday Trade -- Market Talk

Comparación entre iguales

Cambio de precio

Lisata Therapeutics Esperado

Consenso

By TipRanks

0 ratings

Comprar

Mantener

Vender

De acuerdo con 0 analistas que ofrecen calificaciones bursátiles a para Lisata Therapeutics Dist en los últimos 3 meses.

Finanzas

Acerca de Lisata Therapeutics

Lisata Therapeutics, Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of innovative therapies for the treatment of solid tumors and other diseases. Its product candidates include LSTA1, which is in Phase 2a and 2b clinical studies for the treatment of solid tumor, including metastatic pancreatic ductal adenocarcinoma (mPDAC), in combination with a range of anti-cancer regimens; XOWNA that is in Phase IIa clinical trial for the treatment of coronary microvascular dysfunction; and CD34+ cell therapy for the treatment of chronic kidney disease. Lisata Therapeutics, Inc. was incorporated in 1980 and is headquartered in Basking Ridge, New Jersey.